XML 76 R69.htm IDEA: XBRL DOCUMENT
v3.25.3

Commitments and Contingencies - Additional Information (Detail) ¥ in Millions | 1 Months Ended | 9 Months Ended |
--- | --- | --- | ---
May 31, 2024 CNY (¥) | Sep. 30, 2025 USD ($) | Sep. 30, 2025 CNY (¥) | Sep. 30, 2024 USD ($) | Sep. 30, 2025 CNY (¥)
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Purchase of property and equipment |  | $ 1,046,000 |  | $ 2,380,000 |
Property and Equipment |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Purchase of property and equipment |  | 4,600,000 |  |  |
Research and Development |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Committed to allocate |  | $ 24,700,000 |  |  |
Etorel IP Rights |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Contingent royalty minimum payment | ¥ | ¥ 35.0 |  |  |  |
Contingent royalty payment description |  | For each of the first two years starting from June 2025, the minimum annual commission is RMB 10 million, or approximately $1.4 million, based on the September 30, 2025 spot exchange rate, which has already been included in the IP cost. If the sales-based commission calculated at 5% of annual sales in the first year exceeds RMB 10 million (approximately $1.4 million, based on the September 30, 2025 spot exchange rate) or the commission calculated at 4% of annual sales in the second year exceeds RMB 10 million (approximately $1.4 million, based on the September 30, 2025 spot exchange rate), the excess amount for each year will be recognized as contingent consideration. For the third year through the eighth year, the contingent payments will be calculated at 3%, 2%, 2%, 1%, 1%, and 1% of sales in each year, respectively. | For each of the first two years starting from June 2025, the minimum annual commission is RMB 10 million, or approximately $1.4 million, based on the September 30, 2025 spot exchange rate, which has already been included in the IP cost. If the sales-based commission calculated at 5% of annual sales in the first year exceeds RMB 10 million (approximately $1.4 million, based on the September 30, 2025 spot exchange rate) or the commission calculated at 4% of annual sales in the second year exceeds RMB 10 million (approximately $1.4 million, based on the September 30, 2025 spot exchange rate), the excess amount for each year will be recognized as contingent consideration. For the third year through the eighth year, the contingent payments will be calculated at 3%, 2%, 2%, 1%, 1%, and 1% of sales in each year, respectively. |  |
Contingent royalty payment sales for first year | ¥ |  |  | ¥ 10.0 |  |
Contingent royalty payment sales for second year | ¥ |  |  | 10.0 |  |
Contingent royalty payment sales spot exchange rate for first year |  | $ 1,400,000 |  |  |
Contingent royalty payment sales spot exchange rate for second year |  | $ 1,400,000 |  |  |
Contingent royalty payment percentage of sale for first year |  | 5.00% |  |  | 5.00%
Contingent royalty payment percentage of sale for second year |  | 4.00% |  |  | 4.00%
Contingent royalty payments percentage of sale for third year |  | 3.00% |  |  | 3.00%
Contingent royalty payments percentage of sale for fourth year |  | 2.00% |  |  | 2.00%
Contingent royalty payments percentage of sale for fifth year |  | 2.00% |  |  | 2.00%
Contingent royalty payments percentage of sale for sixth year |  | 1.00% |  |  | 1.00%
Contingent royalty payments percentage of sale for seventh year |  | 1.00% |  |  | 1.00%
Contingent royalty payments percentage of sale for eighth year |  | 1.00% |  |  | 1.00%
Minimum payments based on spot exchange rate |  | $ 4,900,000 |  |  |
Minimum annual commission for first two year | ¥ |  |  | ¥ 10.0 |  |
Minimum annual commission sales spot exchange rate for first two year |  | 1,400,000 |  |  |
Annual sales commission for first two years exceeding amount | ¥ |  |  |  |  | ¥ 10.0
Annual sales commission spot exchange rate for first two years exceeding amount |  | $ 1,400,000 |  |  |
Hydronidone |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Contingent royalty payment percentage of sale for first year |  | 10.00% |  |  | 10.00%
Contingent royalty payment percentage of sale for second year |  | 14.00% |  |  | 14.00%
Contingent royalty payments percentage of sale for third year |  | 16.00% |  |  | 16.00%
Contingent royalty payments percentage of sale for fourth year |  | 16.00% |  |  | 16.00%
Contingent royalty payments percentage of sale for fifth year |  | 16.00% |  |  | 16.00%
Contingent royalty payments percentage of sale for sixth year |  | 16.00% |  |  | 16.00%
Contingent royalty payments percentage of sale for seventh year |  | 16.00% |  |  | 16.00%
Contingent royalty payments percentage of sale for eighth year |  | 15.00% |  |  | 15.00%
Contingent royalty payments percentage of sale for ninth year |  | 14.00% |  |  | 14.00%
Contingent royalty payments percentage of sale for tenth year |  | 12.00% |  |  | 12.00%
Contingent royalty payments percentage of sale for eleventh year |  | 10.00% |  |  | 10.00%
Contingent royalty payment percentage of sale for twelfth year |  | 8.00% |  |  | 8.00%
Hydronidone | GNI |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Committed to allocate |  | $ 12,900,000 |  |  |
Hydronidone | Gyre Pharmaceuticals |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Payments for exchange of intellectual property rights |  | 0 |  |  |
Hydronidone | Gyre Pharmaceuticals | Submission of the New Drug Application |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Obligation to pay in exchange for the intellectual property rights |  | 4,700,000 |  |  | ¥ 33.1
Hydronidone | Gyre Pharmaceuticals | NDA Passes the NMPA's Review and Inspection |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Obligation to pay in exchange for the intellectual property rights |  | 1,200,000 |  |  | 8.3
Hydronidone | Gyre Pharmaceuticals | NMPA's Approval of the NDA |  |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |  |
Obligation to pay in exchange for the intellectual property rights |  | $ 7,000,000 |  |  | ¥ 49.6

X
- Definition Annual sales commission for first two years exceeding amount. + References No definition available. + Details
Name: | gyre_AnnualSalesCommissionForFirstTwoYearsExceedingAmount
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Annual sales commission spot exchange rate for first two years exceeding amount. + References No definition available. + Details
Name: | gyre_AnnualSalesCommissionSpotExchangeRateForFirstTwoYearsExceedingAmount
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Commitments and contingencies disclosure. + References No definition available. + Details
Name: | gyre_CommitmentsAndContingenciesDisclosureLineItems
Namespace Prefix: | gyre_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Committed to allocate. + References No definition available. + Details
Name: | gyre_CommittedToAllocate
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Contingent royalty minimum payment. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyMinimumPayment
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Contingent royalty payment description. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentDescription
Namespace Prefix: | gyre_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Contingent royalty payment percentage of sale for eighth year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForEighthYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for eleventh year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForEleventhYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for fifth year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForFifthYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for first year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForFirstYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for fourth year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForFourthYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for ninth year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForNinthYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for second year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForSecondYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for seventh year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForSeventhYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for sixth year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForSixthYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for tenth year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForTenthYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for third year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForThirdYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for twelfth year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForTwelfthYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment sales for first year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentSalesForFirstYear
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Contingent royalty payment sales for second year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentSalesForSecondYear
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Contingent royalty payment sales spot exchange rate for first year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentSalesSpotExchangeRateForFirstYear
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Contingent royalty payment sales spot exchange rate for second year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentSalesSpotExchangeRateForSecondYear
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Minimum annual commission for first two year. + References No definition available. + Details
Name: | gyre_MinimumAnnualCommissionForFirstTwoYear
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Minimum annual commission sales spot exchange rate for first two year. + References No definition available. + Details
Name: | gyre_MinimumAnnualCommissionSalesSpotExchangeRateForFirstTwoYear
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Minimum payments based on spot exchange rate + References No definition available. + Details
Name: | gyre_MinimumPaymentsBasedOnSpotExchangeRate
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Obligation to pay in exchange for the intellectual property rights. + References No definition available. + Details
Name: | gyre_ObligationToPayInExchangeForTheIntellectualPropertyRights
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Payments for exchange for intellectual property rights. + References No definition available. + Details
Name: | gyre_PaymentsForExchangeForIntellectualPropertyRights
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 13 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_CapitalAdditionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=gyre_EtorelIPRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=gyre_HydronidoneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=gyre_GNIMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=gyre_GyrePharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=gyre_SubmissionOfTheNewDrugApplicationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=gyre_NDAPassesTheNMPAsReviewAndInspectionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=gyre_NMPAsApprovalOfTheNDAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |